Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations
Possibilities of antithrombotic therapy in prevention of cardioembolic stroke (CES) in patients with nonvalvular atrial fibrillation (AF) were significantly broadened after new oral anticoagulants (NOC) have been designed and launched into clinical practice (rivaroxaban being one of these agents). I...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2014-05-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/373 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850188071441530880 |
|---|---|
| author | A.V. Fonyakin L.A. Geraskina |
| author_facet | A.V. Fonyakin L.A. Geraskina |
| author_sort | A.V. Fonyakin |
| collection | DOAJ |
| description | Possibilities of antithrombotic therapy in prevention of cardioembolic stroke (CES) in patients with nonvalvular atrial fibrillation (AF) were significantly broadened after new oral anticoagulants (NOC) have been designed and launched into clinical practice (rivaroxaban being one of these agents). In real-life clinical practice, nonvalvular AF can be combined with various cardiovascular pathologies in patients who have had CES, thus giving rise to situations when there are no specific recommendations for NOC. The article analyzes the most common comorbid clinical situation in vascular neurology and evaluates the potential of rivaroxaban as an alternative to warfarin. Rivaroxaban is shown to be a promising drug for widespread use in angio-neurological practice for treating combined cardiovascular pathology. |
| format | Article |
| id | doaj-art-7b73dba157354da9a1cde8d0638470d8 |
| institution | OA Journals |
| issn | 2074-2711 2310-1342 |
| language | Russian |
| publishDate | 2014-05-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Неврология, нейропсихиатрия, психосоматика |
| spelling | doaj-art-7b73dba157354da9a1cde8d0638470d82025-08-20T02:15:58ZrusIMA-PRESS LLCНеврология, нейропсихиатрия, психосоматика2074-27112310-13422014-05-0161485310.14412/2074-2711-2014-1-48-53364Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situationsA.V. Fonyakin0L.A. Geraskina1Neurological Research Center, Russian Academy of Medical Sciences, Moscow, RussiaNeurological Research Center, Russian Academy of Medical Sciences, Moscow, RussiaPossibilities of antithrombotic therapy in prevention of cardioembolic stroke (CES) in patients with nonvalvular atrial fibrillation (AF) were significantly broadened after new oral anticoagulants (NOC) have been designed and launched into clinical practice (rivaroxaban being one of these agents). In real-life clinical practice, nonvalvular AF can be combined with various cardiovascular pathologies in patients who have had CES, thus giving rise to situations when there are no specific recommendations for NOC. The article analyzes the most common comorbid clinical situation in vascular neurology and evaluates the potential of rivaroxaban as an alternative to warfarin. Rivaroxaban is shown to be a promising drug for widespread use in angio-neurological practice for treating combined cardiovascular pathology.https://nnp.ima-press.net/nnp/article/view/373cardioembolic stroke, atrial fibrillation, rivaroxaban. |
| spellingShingle | A.V. Fonyakin L.A. Geraskina Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations Неврология, нейропсихиатрия, психосоматика cardioembolic stroke, atrial fibrillation, rivaroxaban. |
| title | Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations |
| title_full | Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations |
| title_fullStr | Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations |
| title_full_unstemmed | Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations |
| title_short | Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations |
| title_sort | rivaroxaban in secondary prevention of cardioembolic stroke standards and abnormal situations |
| topic | cardioembolic stroke, atrial fibrillation, rivaroxaban. |
| url | https://nnp.ima-press.net/nnp/article/view/373 |
| work_keys_str_mv | AT avfonyakin rivaroxabaninsecondarypreventionofcardioembolicstrokestandardsandabnormalsituations AT lageraskina rivaroxabaninsecondarypreventionofcardioembolicstrokestandardsandabnormalsituations |